<DOC>
	<DOCNO>NCT00698828</DOCNO>
	<brief_summary>To evaluate SUN11031 injection compare placebo subject cachexia associate Chronic Obstructive Pulmonary Disease ( COPD ) determine effect physical performance body composition .</brief_summary>
	<brief_title>SUN11031 Cachexia Associated With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>Male nonpregnant female subject ≥50 year age clinical diagnosis COPD Loss &gt; 5 % subject 's usual body weight Severe anemia ( hemoglobin ≤8 g/dL ) COPD exacerbation Currently undergo treatment evaluation cancer Type I type II diabetes mellitus fast serum glucose ≥115 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cachexia , COPD , Chronic Obstructive Pulmonary Disease</keyword>
</DOC>